QuantaSing Group Limited American Depositary Shares (QSG) had the highest return between December 27, 2023 and January 30, 2024 by a small-cap US stock, returning 142.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
QuantaSing Group Limited American Depositary Shares (QSG) | 12/27/2023 - 1/30/2024 | 142.17% |
Vera Therapeutics (VERA) | 12/27/2023 - 1/30/2024 | 114.08% |
Clene (CLNNW) | 12/27/2023 - 1/30/2024 | 111.08% |
ADC Therapeutics (ADCT) | 12/27/2023 - 1/30/2024 | 94.55% |
Arcutis Biotherapeutics (ARQT) | 12/27/2023 - 1/30/2024 | 92.46% |
Real Brokerage (REAX) | 12/27/2023 - 1/30/2024 | 87.9% |
Immunome (IMNM) | 12/27/2023 - 1/30/2024 | 81.73% |
Praxis Precision Medicines (PRAX) | 12/27/2023 - 1/30/2024 | 72.15% |
Astria Therapeutics (ATXS) | 12/27/2023 - 1/30/2024 | 70.5% |
Dianthus Therapeutics (DNTH) | 12/27/2023 - 1/30/2024 | 69.22% |
Y mAbs Therapeutics (YMAB) | 12/27/2023 - 1/30/2024 | 67.87% |
Dyne Therapeutics (DYN) | 12/27/2023 - 1/30/2024 | 65.86% |
Akso Health Group ADR (AHG) | 12/27/2023 - 1/30/2024 | 64.21% |
Edgewise Therapeutics (EWTX) | 12/27/2023 - 1/30/2024 | 64.1% |
SEALSQ (LAES) | 12/27/2023 - 1/30/2024 | 62.5% |
Yirendai (YRD) | 12/27/2023 - 1/30/2024 | 59.54% |
Establishment Labs (ESTA) | 12/27/2023 - 1/30/2024 | 49.61% |
Cullinan Oncology LLC (CGEM) | 12/27/2023 - 1/30/2024 | 49.28% |
Neuropace (NPCE) | 12/27/2023 - 1/30/2024 | 48.81% |
Kura Oncology (KURA) | 12/27/2023 - 1/30/2024 | 48.08% |
POET Technologies (POET) | 12/27/2023 - 1/30/2024 | 44.44% |
Bright Minds Biosciences (DRUG) | 12/27/2023 - 1/30/2024 | 43.33% |
Spyre Therapeutics (SYRE) | 12/27/2023 - 1/30/2024 | 42.49% |
Kodiak Sciences (KOD) | 12/27/2023 - 1/30/2024 | 42.35% |
Verastem (VSTM) | 12/27/2023 - 1/30/2024 | 41.94% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
